HHS Public Affairs Centralization Plan May Ease FDA Appointment
This article was originally published in The Tan Sheet
Executive Summary
HHS' centralization of public and legislative affairs could help ease some of the anxiety within the pharma-ceutical industry about the possible nomination of Vanderbilt University professor Alastair Wood, MD, as FDA commissioner
You may also be interested in...
FDA Shared Services Chief Expected To Be Selected By July
FDA is targeting early July for selection of a candidate to oversee the agency's new Office of Shared Services, which is slated to begin operations by Oct. 1
CDER “De-Layering” Slated For Late 2003, Following OC Shuffling
FDA's Center for Drug Evaluation & Research will be reorganized along with the rest of the agency's centers in mid- to late-2003
HHS Public, Legislative Affairs Centralization Will Shift 80 FTEs From FDA
FDA will transfer 80 full-time equivalent positions to HHS as part of the department's centralization of public and legislative affairs activities